HUANG Yun,HUANG Shunwang,QIAO Jinwei,et al.Research progress on the chemical constituents, pharmacological mechanisms and clinical application of Jiegeng decoction[J].ZHONGGUO YAOFANG,2025,36(18):2348-2352.
HUANG Yun,HUANG Shunwang,QIAO Jinwei,et al.Research progress on the chemical constituents, pharmacological mechanisms and clinical application of Jiegeng decoction[J].ZHONGGUO YAOFANG,2025,36(18):2348-2352. DOI: 10.6039/j.issn.1001-0408.2025.18.23.
Research progress on the chemical constituents, pharmacological mechanisms and clinical application of Jiegeng decoction
Jiegeng decoction is a classic prescription composed of two Chinese medicinal herbs:
Platycodon grandiflorum
and
Glycyrrhiza uralensis
. It has the efficacy of diffusing lung qi, resolving phlegm, relieving sore throat and discharging pus, and is commonly used in the treatment of respiratory diseases such as cough and pharyngodynia. This article reviews the chemical components, pharmacological mechanisms and clinical applications of Jiegeng decoction. It was found that Jiegeng decoction contain
s triterpenoid saponins, flavonoids, glycosides, acids, and other components, with platycodin D, platycodin D
2
, glycyrrhizic acid, glycyrrhetinic acid, liquiritin, etc., serving as the main active pharmaceutical ingredients. Jiegeng decoction and its chemical constituents exert anti-inflammatory effects by inhibiting signaling pathways such as nuclear factor-κB and mitogen-activated protein kinases, and demonstrate anti-tumor activities through mechanisms like modulating the tumor immune microenvironment and promoting cancer cell apoptosis. Additionally, it exhibits various pharmacological actions including antibacterial, antiviral, and antioxidant effects. Clinically, Jiegeng decoction, its modified prescription and compound combinations are widely used in the treatment of respiratory diseases such as cough, pneumonia, and pharyngitis, as well as digestive system disorders like constipation.
GAO W , GUO Y , YANG H X . Platycodin D protects against cigarette smoke-induced lung inflammation in mice [J ] . Int Immunopharmacol , 2017 , 47 : 53 - 58 .
HUANG H , WU D , LI Q , et al . Jiegeng decoction ameliorated acute pharyngitis through suppressing NF-κB and MAPK signaling pathways [J ] . J Ethnopharmacol , 2024 , 332 : 118328 .
WU Z H , LUO Z Q , SUN W , et al . Integrating network pharmacology and experimental validation to elucidate the mechanism of Jiegeng decoction in improving allergic asthma [J ] . ACS Omega , 2023 , 8 ( 50 ): 48081 - 48090 .
CHEN H F , LI G F , LIU Y , et al . Jiegeng decoction potentiates the anticancer efficacy of paclitaxel in vivo and in vitro [J ] . Front Pharmacol , 2022 , 13 : 827520 .
WANG L Q , YANG R , YUAN B C , et al . The antiviral and antimicrobial activities of licorice,a widely-used Chinese herb [J ] . Acta Pharm Sin B , 2015 , 5 ( 4 ): 310 - 315 .
XIE Y , HE S W , SUN H X , et al . Platycodin D 2 improves specific cellular and humoral responses to hepatitis B surface antigen in mice [J ] . Chem Biodivers , 2010 , 7 ( 1 ): 178 - 185 .
YI Y , LI W Z , LIU K F , et al . Licorice-saponin A 3 is a broad-spectrum inhibitor for COVID-19 by targeting viral spike and anti-inflammation [J ] . J Pharm Anal , 2024 , 14 ( 1 ): 115 - 127 .
XU Y , WANG X , HAN D , et al . Revealing the mechanism of Jiegeng decoction attenuates bleomycin-induced pulmonary fibrosis via PI3K/Akt signaling pathway based on lipidomics and transcriptomics [J ] . Phytomedicine , 2022 , 102 : 154207 .